Dottorini_J Nucl Med_1995
The aim of the present study was to compare the risk in differentiated thyroid carci noma patients treated with I31Iand those not treated with Iodine-131 *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
- Start Year
- End Year
- Study design
- Clinical trial cohort
- Follow Up
- The mean follow-up was 7.44 years for the patients of Group A and 10.3 years for the patients of Group B.
Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med. 1995 Jan;36(1):21-7.
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
- Supplementary Information
- Females of child-bearing age (patients with thyroid cancer)
Availability of data and biosamples
No coverage data about the variables classifications are available.